Roberto Piñeiro

Dr. Roberto Piñeiro

Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela-CHUS, 15706,Santiago de Compostela, Spain
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2014 in Nature
Verified
Journal Article
Open access
PDF file
KAKhaled Ali
Khaled Ali
DSDalya R. Soond
Dalya R. Soond
RPRoberto Piñeiro
Roberto Piñeiro
THThorsten Hagemann
Thorsten Hagemann
WPWayne Pearce
Wayne Pearce
BVBart Vanhaesebroeck
Bart Vanhaesebroeck
The kinase PI(3)Kδ is shown to be required for the immunosuppressive function of regulatory T cells; inactivation of PI(3)Kδ in these cells leads to enhanced cytotoxic T-cell function and restricts tumour growth and metastasis in a variety of mouse tumour models. This paper shows that the p110δ isoform of phosphoinositide-3-OH kinase (PI(3)K) is critically required for the immunosuppressive function of regulatory T (Treg) cells. Inactivation of p110δ in Treg cells leads to enhanced cytotoxic T-cell function and restricts tumour growth and metastasis in a variety of mouse tumour models. This finding identifies p110δ as a druggable kinase target for which inhibition boosts the cancer-suppressive potential of the immune system. Inhibitors against the p110δ isoform of phosphoinositide-3-OH kinase (PI(3)K) have shown remarkable therapeutic efficacy in some human leukaemias1,2. As p110δ is primarily expressed in leukocytes3, drugs against p110δ have not been considered for the treatment of solid tumours4. Here we report that p110δ inactivation in mice protects against a broad range of cancers, including non-haematological solid tumours. We demonstrate that p110δ inactivation in regulatory T cells unleashes CD8+ cytotoxic T cells and induces tumour regression. Thus, p110δ inhibitors can break tumour-induced immune tolerance and should be considered for wider use in oncology.

26 August 2005 in FEBS Letters
Verified
Journal Article
Closed access
RPRoberto Piñeiro
Roberto Piñeiro
MMMaria Jesus Iglesias Mareque
Maria Jesus Iglesias Mareque
RGRosalía Gallego
Rosalía Gallego
KRKawtar Raghay
Kawtar Raghay
SESonia Eiras
Sonia Eiras
FLFrancisca Lago
Francisca Lago

13 September 2010 in Oncogene
Verified
Journal Article
Closed access
RPRoberto Piñeiro
Roberto Piñeiro
TMT Maffucci
T Maffucci
Marco FalascaMarco Falasca
Marco Falasca

10 December 2015 in Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
BVBart Vanhaesebroeck
Bart Vanhaesebroeck
MWMaria A. Whitehead
Maria A. Whitehead
RPRoberto Piñeiro
Roberto Piñeiro

5 October 2020 in Cancers
Verified
Journal Article
Open access
PDF file
PHPablo Hurtado
Pablo Hurtado
IMInés Martínez-Pena
Inés Martínez-Pena
RPRoberto Piñeiro
Roberto Piñeiro
The crosstalk between cancer cells and the tumor microenvironment (TME) is a key determinant of cancer metastasis. Cancer-associated fibroblasts (CAFs), one of the main cellular components of TME, promote cancer cell invasion and dissemination through mechanisms including cell-cell interactions and the paracrine secretion of growth factors, cytokines and chemokines. During metastasis, circulating tumor cells (CTCs) are shed from the primary tumor to the bloodstream, where they can be detected as single cells or clusters. The current knowledge about the biology of CTC clusters positions them as key actors in metastasis formation. It also indicates that CTCs do not act alone and that they may be aided by stromal and immune cells, which seem to shape their metastatic potential. Among these cells, CAFs are found associated with CTCs in heterotypic CTC clusters, and their presence seems to increase their metastatic efficiency. In this review, we summarize the current knowledge on the role that CAFs play on metastasis and we discuss their implication on the biogenesis, metastasis-initiating capacity of CTC clusters, and clinical implications. Moreover, we speculate about possible therapeutic strategies aimed to limit the metastatic potential of CTC clusters involving the targeting of CAFs as well as their difficulties and limitations.

1 April 2012 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
RPRoberto Piñeiro
Roberto Piñeiro
Marco FalascaMarco Falasca
Marco Falasca